Key result
Aldosterone augments AT1R-dependent activation of ERK1/2, JNK, and NF-kappaB in vascular smooth muscle cells, demonstrating that its nongenomic and genomic effects depend on AT1aR and AT1bR activity.
Why the study?
Does aldosterone-induced activation of signaling pathways require AT1aR or AT1bR activity in mouse VSMCs?
Does aldosterone-induced activation of signaling pathways require AT1aR or AT1bR activity in mouse VSMCs?
Answers are grounded in this paper and cite their sources.
Aldosterone augments AT1R-dependent activation of ERK1/2, JNK, and NF-kappaB in VSMCs, providing mechanistic support for dual blockade of AT1R and MR in hypertension and heart failure.
RATIONALE: Aldosterone has been shown to induce vascular damage, endothelial dysfunction, and myocardial fibrosis, which depend in part on activation of angiotensin II (Ang II)-mediated pathways. However, mechanisms underlying crosstalk between Ang II type 1 receptor (AT(1)R) and mineralocorticoid receptor (MR) are mostly unknown. OBJECTIVES: We tested whether the lack of Ang II type 1a receptor (AT(1a)R) or Ang II type 1b receptor (AT(1b)R) would decrease cellular effects induced by aldosterone. METHODS AND RESULTS: We examined the effect of Ang II or aldosterone after transfection of mesenteric vascular smooth muscle cells (VSMCs) from C57Bl/6 mice with small interference RNA for AT(1a)R, AT(1b)R, or MR for 48 hours. Ang II and aldosterone separately induced ERK1/2, c-Jun NH2-terminal protein kinase (JNK), and nuclear factor (NF)-kappaB phosphorylation after a 20-minute stimulation. Small interference RNA for AT(1a)R downregulated phosphorylation of ERK1/2, JNK, and NF-kappaB after aldosterone stimulation compared to controls. Downregulation of AT(1b)R or MR only abolished the activation of NF-kappaB. In VSMCs from C57Bl/6 mice, aldosterone and Ang II induced the activation of the c-fos promoter from 30 minutes to 1 hour. This effect was blocked when using VSMCs from AT(1a)R knockout mice. CONCLUSION: We show for the first time that nongenomic and genomic effects of aldosterone are differentially dependent on activity of both AT(1a)R and AT(1b)R. Our data suggest that aldosterone augments AT(1)R-dependent activation of ERK1/2, JNK, and NF-kappaB in VSMCs. We provide mechanistic understanding and experimental in vitro support for the benefit of combination therapy with dual blockade of AT(1)R and MR to treat hypertension and progression of heart failure as reported in clinical studies and animal models.
No takes yet. Share an insight, caveat, or question.
Lemarié et al. (2009) studied Aldosterone-induced vascular damage and signaling. Aldosterone and Angiotensin II stimulation with siRNA for AT1aR, AT1bR, or MR vs. Controls was evaluated on Phosphorylation of ERK1/2, JNK, and NF-kappaB, and activation of c-fos promoter. Aldosterone augments AT1R-dependent activation of ERK1/2, JNK, and NF-kappaB in vascular smooth muscle cells, demonstrating that its nongenomic and genomic effects depend on AT1aR and AT1bR activity.
Synapse has enriched 10 related papers. Consider them for comparative context: